Strategic Collaborations between Hong Kong and Shenzhen in Biotechnology – Capitalising opportunities in the Loop for Policy Innovations
Strategic Collaborations between Hong Kong and Shenzhen in Biotechnology – Capitalising opportunities in the Loop for Policy Innovations
Overlooking the same narrow riverbed stand Hong Kong and Shenzhen, the two major cities of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), whose co-operation in the area of innovation and technology (I&T) has drawn significant attention.
As such, Our Hong Kong Foundation has partnered with the China Center for International Economic Exchanges and the China Development Institute to publish its new Science & Tech Innovation report entitled ‘Strategic Collaborations between Hong Kong and Shenzhen in Biotechnology – Capitalising opportunities in the Loop for Policy Innovations’.
While Hong Kong enjoys a competitive advantage in basic research and a robust capital market, Shenzhen leverages substantial government support to develop mature I&T enterprises and supply chains. Therefore, this report recommends that Hong Kong and Shenzhen use biotechnology as an entry point for scientific and technological innovation cooperation. By taking advantage of the Hetao Shenzhen/Hong Kong Innovation and Technology Co-operation Zone and making use of each cities’ unique advantages, Hong Kong and Shenzhen can pursue common development in this area.
Nevertheless, several problems hinder the two cities’ biotechnology collaboration, including lack of planning, systematic differences, and underdeveloped industrial clusters. Hence, we put forth seven major recommendations for the Hong Kong, Shenzhen, and Central Government to consider. Namely, we recommend speeding up the development of industrial clusters, setting up ancillary facilities, building a one-stop service platform, encouraging technology transfer, and training interdisciplinary talents. We also recommend strengthening overall coordination, bridging the systems of the two cities, and facilitating the flow of biological materials and equipment. For details, please refer to the full report.
We hope to overcome the cooperation challenges of Hong Kong and Shenzhen such that both cities can seize the opportunities brought by the GBA and, by building up the Hetao zone, create a world-class biotech innovation hub together.
Overlooking the same narrow riverbed stand Hong Kong and Shenzhen, the two major cities of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), whose co-operation in the area of innovation and technology (I&T) has drawn significant attention.
As such, Our Hong Kong Foundation has partnered with the China Center for International Economic Exchanges and the China Development Institute to publish its new Science & Tech Innovation report entitled ‘Strategic Collaborations between Hong Kong and Shenzhen in Biotechnology – Capitalising opportunities in the Loop for Policy Innovations’.
While Hong Kong enjoys a competitive advantage in basic research and a robust capital market, Shenzhen leverages substantial government support to develop mature I&T enterprises and supply chains. Therefore, this report recommends that Hong Kong and Shenzhen use biotechnology as an entry point for scientific and technological innovation cooperation. By taking advantage of the Hetao Shenzhen/Hong Kong Innovation and Technology Co-operation Zone and making use of each cities’ unique advantages, Hong Kong and Shenzhen can pursue common development in this area.
Nevertheless, several problems hinder the two cities’ biotechnology collaboration, including lack of planning, systematic differences, and underdeveloped industrial clusters. Hence, we put forth seven major recommendations for the Hong Kong, Shenzhen, and Central Government to consider. Namely, we recommend speeding up the development of industrial clusters, setting up ancillary facilities, building a one-stop service platform, encouraging technology transfer, and training interdisciplinary talents. We also recommend strengthening overall coordination, bridging the systems of the two cities, and facilitating the flow of biological materials and equipment. For details, please refer to the full report.
We hope to overcome the cooperation challenges of Hong Kong and Shenzhen such that both cities can seize the opportunities brought by the GBA and, by building up the Hetao zone, create a world-class biotech innovation hub together.
